Steven Pieper
Förmögenhet: 11 M $ per 2026-08-31
Förmögenhet: 11 M $ per 2026-08-31
Steven M.
Pieper is currently Chief Financial Officer at Xeris Biopharma Holdings, Inc. since 2021.
Formerly, Mr. Pieper was Finance Director at Durata Therapeutics, Inc., Chief Financial & Accounting Officer at Xeris Pharmaceuticals, Inc. in 2021, and Chief Operating & Financial Officer at Catheter Connections, Inc. from 2015 to 2017.
Education includes an undergraduate degree from DePaul University and an MBA from Loyola University of Chicago.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-01 | 1 356 053 ( 0,74 % ) | 11 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Finansdirektör/CFO | 2021-10-01 |
| Företag | Position | Slut |
|---|---|---|
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Finansdirektör/CFO | 2017-01-01 |
| DURATA THERAPEUTICS INC | Finansdirektör/CFO | 2014-11-01 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Finansdirektör/CFO | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån